CN1133594A - 单纯性疱疹病毒-2ul26基因，衣壳蛋白，免疫测定和蛋白酶抑制剂 - Google Patents

单纯性疱疹病毒-2ul26基因，衣壳蛋白，免疫测定和蛋白酶抑制剂 Download PDF

Info

Publication number
CN1133594A
CN1133594A CN94193881A CN94193881A CN1133594A CN 1133594 A CN1133594 A CN 1133594A CN 94193881 A CN94193881 A CN 94193881A CN 94193881 A CN94193881 A CN 94193881A CN 1133594 A CN1133594 A CN 1133594A
Authority
CN
China
Prior art keywords
hsv
ala
pro
seq
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN94193881A
Other languages
English (en)
Chinese (zh)
Inventor
A·G·迪莱拉
C·M·迪布克
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Publication of CN1133594A publication Critical patent/CN1133594A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/705—Specific hybridization probes for herpetoviridae, e.g. herpes simplex, varicella zoster
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56994—Herpetoviridae, e.g. cytomegalovirus, Epstein-Barr virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/01—DNA viruses
    • G01N2333/03—Herpetoviridae, e.g. pseudorabies virus
    • G01N2333/035—Herpes simplex virus I or II

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physiology (AREA)
CN94193881A 1993-08-20 1994-08-19 单纯性疱疹病毒-2ul26基因，衣壳蛋白，免疫测定和蛋白酶抑制剂 Pending CN1133594A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11052293A 1993-08-20 1993-08-20
US08/110522 1993-08-20
US26453794A 1994-06-23 1994-06-23
US08/264537 1994-06-23

Publications (1)

Publication Number Publication Date
CN1133594A true CN1133594A (zh) 1996-10-16

Family

ID=26808107

Family Applications (1)

Application Number Title Priority Date Filing Date
CN94193881A Pending CN1133594A (zh) 1993-08-20 1994-08-19 单纯性疱疹病毒-2ul26基因，衣壳蛋白，免疫测定和蛋白酶抑制剂

Country Status (7)

Country Link
EP (1) EP0714399A4 (fr)
JP (1) JPH09503385A (fr)
CN (1) CN1133594A (fr)
AU (1) AU7568294A (fr)
CA (1) CA2169748A1 (fr)
MX (1) MXPA94006367A (fr)
WO (1) WO1995006055A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102363805A (zh) * 2010-10-15 2012-02-29 成都医学院 一种筛选抗hsv-1药物的试剂盒和方法
CN107305212A (zh) * 2016-04-25 2017-10-31 赵芳 一种有机磷类和氨基甲酸酯类农药的免疫学检测方法及试剂盒
CN107305213A (zh) * 2016-04-25 2017-10-31 赵芳 一种检测有机磷类和氨基甲酸酯类农药的方法及试剂盒
CN116287432A (zh) * 2022-09-29 2023-06-23 北京生物制品研究所有限责任公司 荧光定量pcr法鉴别单纯疱疹病毒i型和/或ii型的试剂及其应用

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083711A (en) * 1996-05-15 2000-07-04 Smithkline Beecham Corporation Proteases compositions capable of binding to said site, and methods of use thereof
US6617103B1 (en) 1996-07-01 2003-09-09 The United States Of America As Represented By The Department Of Health And Human Services Identification of a transforming fragment of herpes simplex type 2 and detection thereof in clinical specimens
CA2270282A1 (fr) * 1996-11-04 1998-05-14 Smithkline Beecham Corporation Nouvelles sequences codantes pour le virus herpes simplex de type 2
US6143513A (en) * 1999-06-23 2000-11-07 Biacore Ab Method and kit for detecting betalactam-containing compounds
DK1523582T3 (da) 2002-07-18 2009-03-02 Univ Washington Hurtig, effektiv rensning af HSV-specifikke T-lymfocytter samt HSV-antigener identificeret derved
US8460674B2 (en) 2009-02-07 2013-06-11 University Of Washington HSV-1 epitopes and methods for using same
WO2010115172A2 (fr) 2009-04-03 2010-10-07 University Of Washington Peptide antigénique de hsv-2 et procédés d'utilisation de celui-ci
EP3756684A1 (fr) 2009-05-22 2020-12-30 Genocea Biosciences, Inc. Vaccins contre le virus de l'herpès simplex de type 2 : compositions et procédés pour obtenir une réponse immunitaire
EP2643014A4 (fr) 2010-11-24 2015-11-11 Genocea Biosciences Inc Vaccins contre le virus de type 2 de l'herpès simplex: compositions et procédés pour la stimulation d'une réponse immunitaire
EP2782597B1 (fr) 2011-11-23 2022-04-13 Genocea Biosciences, Inc. Vaccins à acide nucléique contre le virus d'herpès simplex de type 2 : compositions et procédés pour susciter une réponse immunitaire
JP2019537555A (ja) 2016-09-28 2019-12-26 ジェノセア バイオサイエンシーズ， インコーポレイテッド ヘルペスを処置するための方法および組成物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4430437A (en) * 1980-08-27 1984-02-07 The United States Of America As Represented By The Department Of Health And Human Services Test methods employing monoclonal antibodies against Herpes simplex virus types 1 and 2 nucleocapsids proteins
US4709011A (en) * 1982-02-18 1987-11-24 University Patents, Inc. Materials and methods for herpes simplex virus vaccination
US4891315A (en) * 1982-10-25 1990-01-02 American Cyanamid Company Production of herpes simplex viral porteins
US4618578A (en) * 1984-07-17 1986-10-21 Chiron Corporation Expression of glycoprotein D of herpes simplex virus
US5324664A (en) * 1988-08-08 1994-06-28 The Upjohn Company Herpes virus thymidien kinase-encoding DNA
US5122449A (en) * 1988-10-07 1992-06-16 Eastman Kodak Company Use of a protease in the extraction of chlamydial, gonococcal and herpes antigens
JP3167138B2 (ja) * 1991-02-25 2001-05-21 株式会社ヤトロン 単純ヘルペスウイルスの型特異的検出方法
NZ242739A (en) * 1991-05-24 1994-12-22 Arch Dev Corp Identification and purification of herpes protease nucleic acid segments and their use in the production of this protease
US5434074A (en) * 1991-07-05 1995-07-18 Gibson; D. Wade Cytomegalovirus proteinase
WO1994029456A2 (fr) * 1993-06-08 1994-12-22 Abbott Laboratories Protease associee au virus de l'herpes du type 2

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102363805A (zh) * 2010-10-15 2012-02-29 成都医学院 一种筛选抗hsv-1药物的试剂盒和方法
CN107305212A (zh) * 2016-04-25 2017-10-31 赵芳 一种有机磷类和氨基甲酸酯类农药的免疫学检测方法及试剂盒
CN107305213A (zh) * 2016-04-25 2017-10-31 赵芳 一种检测有机磷类和氨基甲酸酯类农药的方法及试剂盒
CN107305212B (zh) * 2016-04-25 2019-08-30 赵芳 一种有机磷类和氨基甲酸酯类农药的免疫学检测方法及试剂盒
CN116287432A (zh) * 2022-09-29 2023-06-23 北京生物制品研究所有限责任公司 荧光定量pcr法鉴别单纯疱疹病毒i型和/或ii型的试剂及其应用

Also Published As

Publication number Publication date
EP0714399A1 (fr) 1996-06-05
MXPA94006367A (es) 2004-09-09
JPH09503385A (ja) 1997-04-08
EP0714399A4 (fr) 1999-01-27
WO1995006055A1 (fr) 1995-03-02
AU7568294A (en) 1995-03-21
CA2169748A1 (fr) 1995-03-02

Similar Documents

Publication Publication Date Title
CN1133594A (zh) 单纯性疱疹病毒-2ul26基因，衣壳蛋白，免疫测定和蛋白酶抑制剂
CN1197962C (zh) 用于测序的改变的热稳定dna聚合酶
CN1823166A (zh) 血红蛋白a1c的测定方法和用于此目的的酶及其生产方法
CN1324147C (zh) 细小病毒b19的诊断测试
CN1798851A (zh) 通过核酸扩增检测1型和2型单纯疱疹病毒
CN1553962A (zh) 蛋白酶检测系统
CN1515669A (zh) 由氧化葡糖杆菌t-100得到的l-山梨酮脱氢酶
CN1177054C (zh) D-山梨醇脱氢酶基因
CN1467500A (zh) 免疫学测定方法、免疫测定用试剂及其制造方法
CN1193997A (zh) 产生和纯化并测定具有hcvns3蛋白酶蛋白水解活性的多肽的方法
CN1128879C (zh) 超耐热蛋白酶基因
CN1263855C (zh) 来自淡青链霉菌的假寡糖生物合成基因的分离及其应用
CN1264988C (zh) 应用聚合酶链反应对小麦真菌病原体的检测
CN1920562A (zh) Eb病毒蛋白酶联免疫吸附诊断试剂盒及其制备方法
CN1550502A (zh) 用于由大肠杆菌向培养基中分泌来制备Leu-水蛭素的信号序列
CN1896105A (zh) 修饰重组的人乳头瘤病毒多肽、衣原体热休克多肽、肿瘤多肽及肿瘤阻抑蛋白多肽
CN1635159A (zh) 结核分枝杆菌耐药基因检测试剂盒及其制备方法
CN1087915A (zh) 用于丙型肝炎病毒分类的抗原肽,含有所述肽的药盒及用所述肽进行分类的方法
CN1514878A (zh) 在生物样品中检测钙蛋白酶3活性的方法和实施该方法所用的肽
CN1391612A (zh) 来自嗜热棒状杆菌的氨基酸生物合成途径的抗热酶的基因
CN1213402A (zh) 表层蛋白的重组表达
CN1219200A (zh) 谷氨酸脱氢酶、β－N－乙酰氨基己糖苷酶和γ－肌动蛋白基因的启动子以及它们在丝状真菌表达,分泌和反义系统中的应用
CN1190129A (zh) 棉子糖合酶基因及其用途
CN1458976A (zh) 2,5－dkg通透酶
CN1163604C (zh) 减毒水痘病毒冈株的基因62和利用基因62的减毒水痘活疫苗用病毒株的鉴定方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)